Literature DB >> 30102383

The Effects of Tobacco Smoking, and Prenatal Tobacco Smoke Exposure, on Risk of Schizophrenia: A Systematic Review and Meta-Analysis.

Abby Hunter1, Rachael Murray1, Laura Asher2, Jo Leonardi-Bee1.   

Abstract

BACKGROUND: The association between cigarette smoking and schizophrenia is well established. However, up to 90% of people with schizophrenia begin smoking before the onset of their illness; thus, smoking could be an independent risk factor for schizophrenia. Prenatal exposure to maternal cigarette smoke is also associated with psychiatric problems in adolescence. Therefore, our aim was to undertake a systematic review and meta-analysis to explore the effect of smoking, and prenatal smoke exposure, on risk of schizophrenia.
METHOD: We systematically searched Medline, EMBASE, PsychInfo, Maternity and Infant Care, and Web of Science (from inception to February 2018) to identify comparative observational studies of the risk of schizophrenia in relation to smoking status. Measures of relative risk (RR) were pooled in a meta-analysis with 95% confidence intervals (CI), using random effects model.
RESULTS: Twelve studies (9 cohort, 3 case-control) were included. Odds ratios (OR) and hazard ratios (HR) were pooled together to estimate pooled relative risks and estimates combined in a meta-analysis on an assumption of constant risk over time. Smokers had a significantly increased risk of schizophrenia compared with nonsmokers (RR = 1.99, 95% CI = 1.10% to 3.61%, I2 = 97%, 5 studies). Exposure to prenatal smoke increased the risk of schizophrenia by 29% (95% CI = 1.10% to 1.51%, I2 = 71%, 7 studies). Sensitivity analyses identified no significant differences between the results from studies reporting OR and hazard ratio.
CONCLUSIONS: Our findings suggest smoking, and prenatal smoke exposure, may be an independent risk factor for schizophrenia. Care should be taken when inferring causation, given the observational nature of the studies. IMPLICATIONS: In this meta-analysis of 12 studies, smokers had a significantly increased risk of schizophrenia compared with nonsmokers. Exposure to prenatal tobacco smoke also increased the risk of schizophrenia by 29% compared with those with no exposure to prenatal tobacco smoke. Our findings suggest that smoking, and prenatal tobacco smoke exposure, may be independent risk factors for schizophrenia. These results may have important public health implications for decreasing the incidence of schizophrenia. The possibility of a causal link between smoking and schizophrenia warrants further investigation.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 30102383     DOI: 10.1093/ntr/nty160

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  13 in total

1.  Need to Account for Familial Confounding in Systematic Review and Meta-analysis of Prenatal Tobacco Smoke Exposure and Schizophrenia.

Authors:  Patrick D Quinn; Sandra M Meier; Brian M D'Onofrio
Journal:  Nicotine Tob Res       Date:  2020-10-08       Impact factor: 4.244

2.  The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort.

Authors:  A Garosi; P L Sunhary de Verville; D Etchecopar-Etchart; R Richieri; O Godin; F Schürhoff; F Berna; B Aouizerate; D Capdevielle; I Chereau; J Clauss-Kobayashi; J M Dorey; C Dubertret; N Coulon; S Leignier; J Mallet; D Misdrahi; C Passerieux; R Rey; A Szoke; M Urbach; M Leboyer; P M Llorca; C Lançon; L Boyer; G Fond
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-19       Impact factor: 5.760

Review 3.  Prenatal Maternal Stress and the Cascade of Risk to Schizophrenia Spectrum Disorders in Offspring.

Authors:  Emily Lipner; Shannon K Murphy; Lauren M Ellman
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

4.  A meta-review of "lifestyle psychiatry": the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders.

Authors:  Joseph Firth; Marco Solmi; Robyn E Wootton; Davy Vancampfort; Felipe B Schuch; Erin Hoare; Simon Gilbody; John Torous; Scott B Teasdale; Sarah E Jackson; Lee Smith; Melissa Eaton; Felice N Jacka; Nicola Veronese; Wolfgang Marx; Garcia Ashdown-Franks; Dan Siskind; Jerome Sarris; Simon Rosenbaum; André F Carvalho; Brendon Stubbs
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

5.  Need for Ethnic and Population Diversity in Psychosis Research.

Authors:  Carla Burkhard; Saba Cicek; Ran Barzilay; Rajiv Radhakrishnan; Sinan Guloksuz
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

Review 6.  Evidence of a Causal Relationship Between Smoking Tobacco and Schizophrenia Spectrum Disorders.

Authors:  James G Scott; Lori Matuschka; Solja Niemelä; Jouko Miettunen; Brett Emmerson; Antti Mustonen
Journal:  Front Psychiatry       Date:  2018-11-20       Impact factor: 4.157

Review 7.  Environmental Risk Factors and Health: An Umbrella Review of Meta-Analyses.

Authors:  David Rojas-Rueda; Emily Morales-Zamora; Wael Abdullah Alsufyani; Christopher H Herbst; Salem M AlBalawi; Reem Alsukait; Mashael Alomran
Journal:  Int J Environ Res Public Health       Date:  2021-01-15       Impact factor: 3.390

Review 8.  How do established developmental risk-factors for schizophrenia change the way the brain develops?

Authors:  Darryl W Eyles
Journal:  Transl Psychiatry       Date:  2021-03-08       Impact factor: 6.222

9.  Associations of cigarette smoking with psychiatric disorders: evidence from a two-sample Mendelian randomization study.

Authors:  Shuai Yuan; Honghui Yao; Susanna C Larsson
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

Review 10.  Smoking and Neuropsychiatric Disease-Associations and Underlying Mechanisms.

Authors:  Omar Hahad; Andreas Daiber; Matthias Michal; Marin Kuntic; Klaus Lieb; Manfred Beutel; Thomas Münzel
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.